Litcius/Paper detail

Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab

Fatma Alıbaz-Öner, Sema Kaymaz‐Tahra, Ö. Bayındır, Ayten Yazıcı, B. İnce, Kübra Kalkan, Nilüfer Alpay Kanıtez, Sinem Burcu Kocaer, Nazife Şule Yaşar Bilge, Ahmet Omma, Elif Durak, Can Ilgın, Servet Akar, Timuçin Kaşifoğlu, Fatoş Önen, Hakan Emmungil, Murat İnanç, Ayşe Çefle, Kenan Aksu, Gökhan Keser, Haner Di̇reskeneli̇

2021Seminars in Arthritis and Rheumatism39 citationsDOI

Topics & Concepts

MedicineTocilizumabAdalimumabInternal medicineInfliximabAnakinraDiscontinuationConcomitantGastroenterologyEtanerceptSurgeryInterquartile rangeTumor necrosis factor alphaRheumatoid arthritisDiseaseVasculitis and related conditionsRenal Diseases and GlomerulopathiesPregnancy and Medication Impact
Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab | Litcius